OLFM4 and metabolic dysfunction-associated steatotic liver disease: First, when we analysed OLFM2 and OLFM4 relative mRNA expressions between NL and NAFLD in hepatic and jejunal samples, respectively, we only reported significant differences between groups in the case of OLFM2 (p = 0.005).